Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Suppression of anchorage-independent growth by expression of the ataxia-telangiectasia group D complementing gene, ATDC.

Hosoi Y, Kapp LN, Murnane JP, Matsumoto Y, Enomoto A, Ono T, Miyagawa K.

Biochem Biophys Res Commun. 2006 Sep 22;348(2):728-34. Epub 2006 Jul 28.

PMID:
16890201
2.
3.

Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.

Tang ZP, Dong QZ, Cui QZ, Papavassiliou P, Wang ED, Wang EH.

PLoS One. 2013 Jun 12;8(6):e63676. doi: 10.1371/journal.pone.0063676. Print 2013.

4.

Expression of the candidate A-T gene ATDC is not detectable in a human cell line with a normal response to ionizing radiation.

Murnane JP, Zhu Y, Young BR, Christman MF.

Int J Radiat Biol. 1994 Dec;66(6 Suppl):S77-84.

PMID:
7836856
5.

The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor.

Brzoska PM, Chen H, Zhu Y, Levin NA, Disatnik MH, Mochly-Rosen D, Murnane JP, Christman MF.

Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7824-8.

6.

Expression of the ATDC (ataxia telangiectasia group D-complementing) gene in A431 human squamous carcinoma cells.

Laderoute KR, Knapp AM, Green CJ, Sutherland RM, Kapp LN.

Int J Cancer. 1996 Jun 11;66(6):772-8.

7.

Nucleotide sequence analysis of a candidate gene for ataxia-telangiectasia group D (ATDC).

Leonhardt EA, Kapp LN, Young BR, Murnane JP.

Genomics. 1994 Jan 1;19(1):130-6.

PMID:
8188213
8.

Cloning of a candidate gene for ataxia-telangiectasia group D.

Kapp LN, Painter RB, Yu LC, van Loon N, Richard CW 3rd, James MR, Cox DR, Murnane JP.

Am J Hum Genet. 1992 Jul;51(1):45-54.

9.

Altered splicing of the ATDC message in ataxia telangiectasia group D cells results in the absence of a functional protein.

Tauchi H, Green C, Knapp M, Laderoute K, Kapp L.

Mutagenesis. 2000 Mar;15(2):105-8.

PMID:
10719033
10.

Down-regulating ATDC inhibits the proliferation of esophageal carcinoma cells.

Lai W, Zheng X, Huang Q, Wu X, Yang M.

Eur Rev Med Pharmacol Sci. 2014 Nov;18(22):3511-6.

12.
13.

Gene amplification and overexpression of PRDM14 in breast cancers.

Nishikawa N, Toyota M, Suzuki H, Honma T, Fujikane T, Ohmura T, Nishidate T, Ohe-Toyota M, Maruyama R, Sonoda T, Sasaki Y, Urano T, Imai K, Hirata K, Tokino T.

Cancer Res. 2007 Oct 15;67(20):9649-57.

14.

Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.

Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ.

Breast Cancer Res Treat. 2009 Feb;113(3):443-56. doi: 10.1007/s10549-008-9956-x. Epub 2008 Mar 10.

PMID:
18327707
15.

Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.

Tao Q, Fujimoto J, Men T, Ye X, Deng J, Lacroix L, Clifford JL, Mao L, Van Pelt CS, Lee JJ, Lotan D, Lotan R.

J Natl Cancer Inst. 2007 Nov 21;99(22):1668-82. Epub 2007 Nov 13.

PMID:
18000218
16.

Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.

Wang J, Yang Y, Xia HH, Gu Q, Lin MC, Jiang B, Peng Y, Li G, An X, Zhang Y, Zhuang Z, Zhang Z, Kung HF, Wong BC.

Gastroenterology. 2007 Mar;132(3):1066-76. Epub 2006 Dec 3.

PMID:
17383428
17.

SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.

Wang H, McKnight NC, Zhang T, Lu ML, Balk SP, Yuan X.

Cancer Res. 2007 Jan 15;67(2):528-36.

18.

The transcription factor ITF-2A induces cell cycle arrest via p21(Cip1).

Herbst A, Helferich S, Behrens A, Göke B, Kolligs FT.

Biochem Biophys Res Commun. 2009 Oct 2;387(4):736-40. doi: 10.1016/j.bbrc.2009.07.102. Epub 2009 Jul 25.

PMID:
19635457
19.

Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.

Ko JM, Chan PL, Yau WL, Chan HK, Chan KC, Yu ZY, Kwong FM, Miller LD, Liu ET, Yang LC, Lo PH, Stanbridge EJ, Tang JC, Srivastava G, Tsao SW, Law S, Lung ML.

Mol Cancer Res. 2008 Apr;6(4):592-603. doi: 10.1158/1541-7786.MCR-07-0154.

20.

ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.

Herbst A, Bommer GT, Kriegl L, Jung A, Behrens A, Csanadi E, Gerhard M, Bolz C, Riesenberg R, Zimmermann W, Dietmaier W, Wolf I, Brabletz T, Göke B, Kolligs FT.

Gastroenterology. 2009 Aug;137(2):639-48, 648.e1-9. doi: 10.1053/j.gastro.2009.04.049. Epub 2009 Apr 23.

PMID:
19394332

Supplemental Content

Support Center